Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AMGEN INC Director's Dealing 2023

Dec 20, 2023

29819_dirs_2023-12-19_b46e4721-bd3d-49bb-b74f-7953cf737a60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2023-12-18

Reporting Person: Bradner James E. (EVP, R&D, & Chief Sci. Officer)

More from AMGEN INC

Regulatory Filings 2026
May 20
Regulatory Filings 2026
May 19
Interim / Quarterly Report 2026
May 1
Regulatory Filings 2026
Apr 30
Major Shareholding Notification 2026
Apr 29
Regulatory Filings 2026
Apr 22
Proxy Solicitation & Information Statement 2026
Apr 21
Proxy Solicitation & Information Statement 2026
Apr 15
Proxy Solicitation & Information Statement 2026
Apr 7
Proxy Solicitation & Information Statement 2026
Apr 7
View all filings →